Pages that link to "Q24793791"

The following pages link to Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634] (Q24793791):

Displayed 23 items.

• Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis (Q24186852) ‎ (← links)
• Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management (Q26744040) ‎ (← links)
• Managing Sleep Disturbances in Cirrhosis (Q26744541) ‎ (← links)
• Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective (Q26781780) ‎ (← links)
• Concept on the pathogenesis and treatment of primary biliary cirrhosis (Q33866454) ‎ (← links)
• Fatigue in primary biliary cirrhosis (Q34114608) ‎ (← links)
• Primary sclerosing cholangitis: diagnosis and management (Q34498568) ‎ (← links)
• Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience (Q34904107) ‎ (← links)
• Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort (Q35760389) ‎ (← links)
• Physical fitness, fatigue, and quality of life after liver transplantation (Q35880773) ‎ (← links)
• Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. (Q36335752) ‎ (← links)
• Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output (Q36532545) ‎ (← links)
• Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. (Q38738566) ‎ (← links)
• Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. (Q38833243) ‎ (← links)
• Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis (Q39177947) ‎ (← links)
• Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid (Q46102659) ‎ (← links)
• Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment (Q48853559) ‎ (← links)
• The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. (Q54976907) ‎ (← links)
• Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis. (Q55498617) ‎ (← links)
• Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review (Q61856283) ‎ (← links)
• The medical management of primary sclerosing cholangitis (Q81194314) ‎ (← links)
• Primary biliary cirrhosis (Q84230884) ‎ (← links)
• British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis (Q92465727) ‎ (← links)